专题:Pharmaceutical industry and healthcare

This cluster of papers explores the impact of pharmaceutical industry sponsorship on research outcome and quality, including conflicts of interest, financial ties between physicians and industry, direct-to-consumer advertising, publication bias, and ethical considerations in medical practice. The papers investigate the influence of funding sources on clinical trials, prescribing behavior, and the integrity of medical science.
最新文献
Industry Payments to US Physicians by Specialty and Product Type

article Full Text OpenAlex

Awareness and Attitude of Medicine Consumers towards ADR Reporting: A Questionnaire based study of Rural Chhattisgarh

article Full Text OpenAlex

Dentistry Education, Practice, and Research in Argentina

book-chapter Full Text OpenAlex

Why Science and Health Journalism Matters

book-chapter Full Text OpenAlex

Cloudy Evidentiary Standards: Making Sense of the FDA’s “Appropriate for the Protection of the Public Health Standard”

article Full Text OpenAlex

Private consulting firms’ intervention in public health policymaking: An exploratory review

article Full Text OpenAlex

A simple form could prevent authorship issues in Cochrane manuscripts: A cohort study

article Full Text OpenAlex

Recriminalization of drugs in Oregon: The latest backlash

article Full Text OpenAlex

Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety

article Full Text OpenAlex

Are Polish Hospital Pharmacies Ready for Changes in Drug Distribution?

article Full Text OpenAlex

近5年高被引文献
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

article Full Text OpenAlex 230 FWCI53.57901994

Responsible Conduct of Research

book Full Text OpenAlex 203 FWCI60.44093349

Impact of Patient Engagement on Healthcare Quality: A Scoping Review

review Full Text OpenAlex 152 FWCI55.02330503

Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets

paratext Full Text OpenAlex 134 FWCI0

Market strategies used by processed food manufacturers to increase and consolidate their power: a systematic review and document analysis

review Full Text OpenAlex 131 FWCI19.39629159

Medication Without Harm

article Full Text OpenAlex 126 FWCI18.43095884

The gendered nature of authorship

article Full Text OpenAlex 116 FWCI6.93828505

The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice

article Full Text OpenAlex 112 FWCI14.87049022

Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations

review Full Text OpenAlex 93 FWCI44.53841874

Trends in Prescription Drug Launch Prices, 2008-2021

article Full Text OpenAlex 92 FWCI21.2467528